Skip to main content
. 2024 Mar 13;30(6):664–673. doi: 10.1177/13524585241237388

Figure 2.

Figure 2.

Individual sNfL concentration (ng/L) trajectories in the study cohort (N = 44). Patients with relapsing-remitting multiple sclerosis or clinically isolated syndrome had relapse and/or contrast-enhancing lesions at baseline.

Baseline (week 0) is first serum sampling. Blue lines indicate individual patients without disease activity during follow-up, and red lines indicate individuals with disease activity during follow-up. sNfL: serum neurofilament light.